In summary, we developed a novel glycopolymer-basednanocarrierand evaluated the antitumor effect resulting from the combinationof HSV-TK suicide gene therapy, mediated by these HCC-targeted nanosystems,with low concentrations of DTX. Here, TKT is linked to hepatocellular carcinoma.